USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: POTENTIA PHARMACEUTICALS, INC
Address: POTENTIA PHARMACEUTICALS, INC
201 E JEFFERSON ST, STE 312
LOUISVILLE, KY 40202
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $756,798.00 2
STTR Phase I $635,758.00 2
STTR Phase II $977,329.00 1

Award List:

Bypassing fluidics in proteomic screening

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Pascal Deschatelets
Award Amount: $504,000.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to develop a new, groundbreaking technology for the rapid identification of ligands for proteins. Every year, the pharmaceuticals industry loses about $3 billion by targeting genes/proteins wrongfully identified as the cause of… More

Modified bacterial system for vivo direction evolution

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Paul K. Olson
Award Amount: $252,798.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this proposal is to develop a new genetic system that will mimic the natural process of evolution for a selected subset of genes inside of a bacterial cell. Instead of an evolutionary time scale of years, evolution will proceed at an accelerated rate… More

Targeting drug delivery nanoparticles to sites of inflammation

Award Year / Program / Phase: 2008 / STTR / Phase II
Agency: HHS
Research Institution: N/A
Principal Investigator:
Award Amount: $977,329.00
RI Contact: N/A
Abstract:
DESCRIPTION (provided by applicant): The purpose of this Phase II STTR project is to develop a nanoparticle-based drug delivery system for use in the treatment of dry age-related macular degeneration (AMD). AMD is the leading cause of blindness for individ uals over fifty-five years of age that live… More